Andria Nicolaou

Dr. Andria Nicolaou

orcid
University of Cyprus

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CSCharithea Stylianides
Charithea Stylianides
ANAndria Nicolaou
Andria Nicolaou
WSWaqar Aziz Sulaiman
Waqar Aziz Sulaiman
CAChristina-Athanasia Alexandropoulou
Christina-Athanasia Alexandropoulou
IPIlias Panangiotopoulos
Ilias Panangiotopoulos
APAndreas Panayides
Andreas Panayides
Artificial intelligence (AI) is increasingly applied in a wide range of healthcare and Intensive Care Unit (ICU) areas to serve—among others—as a tool for disease detection and prediction, as well as for healthcare resources’ management. Since sepsis is a high mortality and rapidly developing organ dysfunction disease afflicting millions in ICUs and costing huge amounts to treat, the area can benefit from the use of AI tools for early and informed diagnosis and antibiotic administration. Additionally, resource allocation plays a crucial role when patient flow is increased, and resources are limited. At the same time, sensitive data use raises the need for ethical guidelines and reflective datasets. Additionally, explainable AI is applied to handle AI opaqueness. This study aims to present existing clinical approaches for infection assessment in terms of scoring systems and diagnostic biomarkers, along with their limitations, and an extensive overview of AI applications in healthcare and ICUs in terms of (a) sepsis detection/prediction and sepsis mortality prediction, (b) length of ICU/hospital stay prediction, and (c) ICU admission/hospitalization prediction after Emergency Department admission, each constituting an important factor towards either prompt interventions and improved patient wellbeing or efficient resource management. Challenges of AI applications in ICU are addressed, along with useful recommendations to mitigate them. Explainable AI applications in ICU are described, and their value in validating, and translating predictions in the clinical setting is highlighted. The most important findings and future directions including multimodal data use and Transformer-based models are discussed. The goal is to make research in AI advances in ICU and particularly sepsis prediction more accessible and provide useful directions on future work.

15 October 2023
Verified
Conference Paper
Closed access
ANAndria Nicolaou
Andria Nicolaou
MPM. Pantzaris
M. Pantzaris
CLC. P. Loizou
C. P. Loizou
AKA. Kakas
A. Kakas
CPC. S. Pattichis
C. S. Pattichis
Magnetic resonance imaging (MRI) is an essential visualizing tool in the diagnosis and monitoring of Multiple Sclerosis (MS) disease. However, the neurological examinations and the MRI assessments are insufficient to provide personalized treatment to the patients due to the complexity of the disease. This study implemented an explainable artificial intelligence (AI) model with embedded rules to assess MS disease evolution. Clinical data were used including demographic and neurological measurements. Texture features were extracted from manually delineated and normalized brain MRI lesions. Statistical analysis was employed to select the statistically significant texture features and clinical data. Different models using machine learning algorithms were implemented to differentiate the subjects diagnosed with relapsing-remitting MS (RRMS) from the subjects with progressive MS (PMS). Argumentation-based reasoning was performed by modifying the rules extracted from models with the best evaluation results. The findings indicated that the proposed explainable AI model can predict the clinical conditions of MS disease with high accuracy and provide transparent and understandable explanations with high fidelity. Future work will include further clinical data such as medications and investigate the correlation of the texture features and clinical data with the neurological impairment. The proposed model should also be evaluated on more MS subjects.Clinical Relevance— This method can assist clinical experts by providing explainable and interpretable diagnosis in the assessment of MS disease.

22 August 2024
Verified
Book Chapter
Open access
PDF file
ANAndria Nicolaou
Andria Nicolaou
CSCharithea Stylianides
Charithea Stylianides
WSWaqar A. Sulaiman
Waqar A. Sulaiman
ZAZinonas Antoniou
Zinonas Antoniou
LPLakis Palazis
Lakis Palazis
APAndreas Panayides
Andreas Panayides
Explainable artificial intelligence (AI) focuses on developing models and algorithms that provide transparent and interpretable insights into decision-making processes. By elucidating the reasoning behind AI-driven diagnoses and treatment recommendations, explainability can gain the trust of healthcare experts and assist them in difficult diagnostic tasks. Sepsis is characterized as a serious condition that happens when the immune system of the body has an extreme response to an infection, causing tissue and organ damage and leading to death. Physicians face challenges in diagnosing and treating sepsis due to its complex pathogenesis. This work aims to provide an overview of the recent studies that propose explainable AI models in the prediction of sepsis onset and sepsis mortality using intensive care data. The general findings showed that explainable AI can provide the most significant features guiding the decision-making process of the model. Future research will investigate explainability through argumentation theory using intensive care data focused on sepsis patients.

12 February 2025 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
WSWaqar A. Sulaiman
Waqar A. Sulaiman
CSCharithea Stylianides
Charithea Stylianides
ANAndria Nicolaou
Andria Nicolaou
ZAZinonas Antoniou
Zinonas Antoniou
ICIoannis Constantinou
Ioannis Constantinou
Constantinos PattichisConstantinos Pattichis
Constantinos Pattichis
This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.


23 March 2023 in IEEE Access
Verified
Journal Article
Open access
CLChristos P Loizou
Christos P Loizou
KFKevin Fotso
Kevin Fotso
ANAndria Nicolaou
Andria Nicolaou
MPMarios Pantzaris
Marios Pantzaris
MPMarios Pattichis
Marios Pattichis
Constantinos PattichisConstantinos Pattichis
Constantinos Pattichis
Background : Monitoring disease evolution in Multiple sclerosis (MS) subjects may aid in decision making for personalizing treatment and disease evolution prediction. We investigate the use of disability progression, using clinical features, the expanded disability status scale (EDSS), and their relationship with texture features and Amplitude Modulation-Frequency Modulation (AM-FM) features extracted from MRI MS detectable lesions for the prognosis of future disability on magnetic resonance imaging (MRI). Methods : MS detectable brain lesions from N=38 symptomatic untreated subjects diagnosed with clinically isolated syndrome (CIS), were manually segmented, by an experienced MS neurologist, on transverse T2-weighted (T 2 W) images obtained from serial brain MRI scans at the baseline (Time 0M ) and the repeat (Time 6-12M ) examinations. The subjects were separated into two different groups based on their EDSS: (G 1 : 1≤EDSS 2Y ≤3.5 (N=26) and G 2 : 3.5<EDSS 2Y ≤8.5 (N=12) and were monitored over ten years’ time (Time 10Y ). After intensity normalization and image registration, texture and AM-FM features were extracted from all MS lesions at Time 0M and Time 6-12M . The extracted features were used to develop models that correlated with the disease progression in Time 10Y . Results : We found statistically significant differences for features extracted from the two different groups (G 1 vs G 2 at Time 10Y ) and these might be used to predict the development and or the severity of the MS disease. The best model for classifying G 1 vs G 2 subjects at Time 10Y included information taken from the MS lesion images, texture features and AM-FM features extracted from those MS lesion images (with a correct classification score of %CC=94). Conclusions : The proposed methodology may contribute to additional factors for predicting the development and assessing the severity of the MS disease. However, a larger scale study is needed to establish the application in clinical practice and for computing additional features that may provide information for better and earlier differentiation between normal tissue and MS lesions.